Paraneoplastic syndromes in patients with cancer of the larynx and hypopharynx

Annals of Otology, Rhinology and Laryngology

Volumn 116, Issue 7, 2007, Pages 502-513

  Ferlito, Alfio ^a   Rinaldo, Alessandra ^a  

^a UNIVERSITY OF UDINE   (Italy)

Author keywords

Hypopharynx; Larynx; Metastasis; Paraneoplastic syndromes; Recurrence

Indexed keywords

BONE MALFORMATION; CANCER PATIENT; DISEASE ASSOCIATION; EARLY DIAGNOSIS; ENDOCRINE DISEASE; EYE DISEASE; HEMATOLOGIC DISEASE; HUMAN; HYPOPHARYNX CANCER; LARYNX CANCER; MALIGNANT NEOPLASTIC DISEASE; METASTASIS; NEUROLOGIC DISEASE; PARANEOPLASTIC SYNDROME; PRIORITY JOURNAL; RECURRENT DISEASE; REVIEW; SKIN MANIFESTATION; SYMPTOM;

EID: 34447550574     PISSN: 00034894     EISSN: None     Source Type: Journal    
DOI: 10.1177/000348940711600705     Document Type: Review

References (123)

1. Ferlito A, Rinaldo A. Paraneoplastic syndromes in patients with laryngeal and hypopharyngeal cancers. Ann Otol Rhinol Laryngol 2000;109:109-17.
2. Mason WP, Graus F, Lang B, et al. Small-cell lung cancer, paraneoplastic cerebellar degeneration and the Lambert-Eaton myasthenic syndrome. Brain 1997;120:1279-300.
3. Dalmau JO, Posner JB. Paraneoplastic syndromes. Arch Neurol 1999;56:405-8.
4. Sillevis Smitt P, Grefkens J, de Leeuw B, et al. Survival and outcome in 73 anti-Hu positive patients with paraneoplastic encephalomyelitis/sensory neuronopathy. J Neurol 2002;249:745-53.
5. Dropcho EJ. Update on paraneoplastic syndromes. Curr Opin Neurol 2005;18:331-6.
6. Ferlito A, Rinaldo A, Devaney KO. Syndrome of inappropriate antidiuretic hormone secretion associated with head and neck cancers: review of the literature. Ann Otol Rhinol Laryngol 1997;106:878-83.
7. Ferlito A, Shaha AR, Rinaldo A. Paraneoplastic syndromes in neuroendocrine neoplasms of the head and neck: have they an impact on prognosis? Acta Otolaryngol (Stockh) 2001;121:756-8.
8. Kurzrock R, Cohen PR. Cutaneous paraneoplastic syndromes in solid tumors. Am J Med 1995;99:662-71.
9. Oppolzer G, Schwarz T, Zechner G, Gschnait F. Acanthosis nigricans in squamous cell carcinoma of the larynx [in German]. Z Hautkr 1986;61:1229-37.
10. Miller TR, Davis J. Acanthosis nigricans occurring in association with squamous carcinoma of the hypopharynx. N Y State J Med 1954;54:2333-6.
11. Bazex A, Salvador R, Dupré A, Christol B. Syndrome paranéoplasique à type d'hyperkératose des extrémités. Guérison après le traitement de l'épithélioma laryngé. Bull Soc Fr Dermatol Syphil 1965;72:182.
12. Gougerot H, Grupper C. Dermatose érythémato-squameuse avec hyperkératose palmoplantaire, porectasies digitales et cancer de la langue latent. Paris Med 1922;43:234-7.
13. Bolognia JL, Brewer YP, Cooper DL. Bazex syndrome (acrokeratosis paraneoplastica). An analytic review. Medicine (Baltimore) 1991;70:269-80.
14. Amblard P, Reymond JL, Jerome P, Detante J. Double syndrome paranéoplasique dermatomyosite et acrokératose de Bazex. Rev Med Alpes Fr 1979;8:39.
15. Baxter DL Jr, Kallgren DL, Leone KC. Acrokeratosis paraneoplastica of Bazex: report of a case in a young black woman. Cutis 1992;49:265-8.
16. Bazex A, Griffiths A. Acrokeratosis paraneoplastica - a new cutaneous marker of malignancy. Br J Dermatol 1980; 103:301-6.
17. Gago S, Jimenez M, Montes B, Molina L. Síndrome de Bazex o dermatosis psoriasiforme acromélica. Actas Dermosifiliogr 1975;66:321-4.
18. Grimwood RE, Lekan C. Acrokeratosis paraneoplastica with esophageal squamous cell carcinoma. J Am Acad Dermatol 1987;17:685-6.
19. Martin RW III, Cornitius TG, Naylor MF, Neldner KH. Bazex's syndrome in a woman with pulmonary adenocarcinoma. Arch Dermatol 1989;125:847-8.
20. Richard M, Giroux J-M. Acrokeratosis paraneoplastica (Bazex' syndrome). J Am Acad Dermatol 1987;16:178-83.
21. Scarpa C, Nini G, Pasqua MC, Franchi A, Frati C. Singolare osservazione di eritroacrocheratosi paraneoplastica. G Ital Dermatol Minerva Dermatol 1971;46:17-25.
22. Laccourreye O, Laccourreye L, Jouffre V, Brasnu D. Bazex's acrokeratosis paraneoplastica. Ann Otol Rhinol Laryngol 1996;105:487-9.
23. Pecora AL, Landsman L, Imgrund SP, Lambert WC. Acrokeratosis paraneoplastica (Bazex's syndrome). Report of a case and review of the literature. Arch Dermatol 1983;119:820-6.
24. Witkowski JA, Parish LC. Bazex's syndrome. Paraneoplastic acrokeratosis. JAMA 1982;248:2883-4.
25. Khachemoune A, Yalamanchili R, Rodriguez C. Bazex syndrome (paraneoplastic acrokeratosis). Cutis 2004;74:289-92.
26. Valdivielso M, Longo I, Suarez R, Huerta M, Lazaro P. Acrokeratosis paraneoplastica: Bazex syndrome. J Eur Acad Dermatol Venereol 2005;19:340-4.
27. Bazex J, el Sayed F, Sans B, Marguery MC, Samalens G. Acrokératose paranéoplasique de Bazex associée a une ichtyose acquise, des troubles de la pigmentation et un prurit: révélation tardive d'un néoplasme laryngé. Ann Dermatol Venereol 1992;119:483-5.
28. Blanchet F, Leroy D, Deschamps P. Acrokératose paranéoplasique de Bazex. A propos de 8 cas. J Fr Otorhinolaryngol Audiophonol Chir Maxillofac 1980;29:165-9, 171-2.
29. Colomb D, Reboul MC, Mauduit G, Forestier JY. Forme diffuse d'acrokératose paranéoplasique de Bazex révélatrice d'une récidive et de métastases d'un cancer de l'épiglotte antérieurement traité. Ann Dermatol Venereol 1981;108:885-8.
30. Gaillard J, Haguenauer JP, Dubreuil C, Romanet P. Acrokératose de Bazex, syndrome paranéoplasique révélateur d'une métastase d'un cancer de la vallécule guéri localement à trois ans. J Fr Otorhinolaryngol Audiophonol Chir Maxillofac 1978;27:353-7.
31. Legros M, Kalis B, Brunetaud P, Longuebray A. Cancer pharyngo- laryngé et acrokératose de Bazex. Ann Otolaryngol Chir Cervicofac 1977;94:47-52.
32. Miquel FJ, Zapater E, Vilata JJ, Gil MP, Garin L. Paraneoplastic acral hyperkeratosis: initial sign of laryngeal neoplasia. Otolaryngol Head Neck Surg 1997;117:S239-S242.
33. Mounsey R, Brown DH. Bazex syndrome. Otolaryngol Head Neck Surg 1992;107:475-7.
34. Plasencia DP, Lazarich JMC, Macias AR. Acrokeratosis paraneoplastica (Bazex syndrome) with ear manifestation. Mediterranean J Otol 2005;1:148-51.
35. Sarkar B, Knecht R, Sarkar C, Weidauer H. Bazex syndrome (acrokeratosis paraneoplastica). Eur Arch Otorhinolaryngol 1998;255:205-10.
36. Aksu G, Karadeniz A. Cutaneous paraneoplastic syndrome (acrokeratosis paraneoplastica) preceding squamous cell carcinoma of the glottic larynx. N Z Med J 2006;119:U2006.
37. Schoeffler A, Sagot V, Marzin A, et al. Bullous paraneoplastic acrokeratosis [in French]. Ann Dermatol Venereol 2006; 133:557-60.
38. Milewski C, Wieland W. Paraneoplastische Akrokeratose: M. Bazex. Eine tumorspezifische Dermatose bei Plattenepithelkarzinomen im Kopf-Halsbereich. HNO 1988;36:158-60.
39. Wareing MJ, Vaughan-Jones SA, McGibbon DH. Acrokeratosis paraneoplastica: Bazex syndrome. J Laryngol Otol 1996;110:899-900.
40. Halpern SM, O'Donnell LJD, Makunura CN. Acrokeratosis paraneoplastica of Bazex in association with a metastatic neuroendocrine tumour. J R Soc Med 1995;88:353P-354P.
41. Wishart JM. Bazex paraneoplastic acrokeratosis: a case report and response to Tigason. Br J Dermatol 1986;115:595-9.
42. Le T, Pierard GE. Etude clinique et histologique de l'effet d'un rétinoïde aromatique Ro 10-9359 sur un syndrome apparenté à l'acrokératose paranéoplasique de Bazex. Dermatologica 1982;165:559-67.
43. Cohen PR. Bowen's disease: squamous cell carcinoma in situ. Am Fam Physician 1991;44:1325-9.
44. Hodge L, Marsden RA, Black MM, Bhogal B, Corbett MF. Bullous pemphigoid: the frequency of mucosal involvement and concurrent malignancy related to indirect immunofluorescence findings. Br J Dermatol 1981;105:65-9.
45. Bonnetblanc JM, Bernard P, Fayol J. Dermatomyositis and malignancy. A multicenter cooperative study. Dermatologica 1990;180:212-6.
46. Mackenzie AH, Scherbel AL. Connective tissue syndromes associated with carcinoma. Geriatrics 1963;18:745-53.
47. Rantuccio F. Incidence of malignancy in patients with generalized pruritus [Letter]. J Am Acad Dermatol 1989;21: 1317.
48. Cormia FE. Pruritus, an uncommon but important symptom of systemic carcinoma. Arch Dermatol 1965;92:36-9.
49. Kantor GR, Lookingbill DP. Generalized pruritus and systemic disease. J Am Acad Dermatol 1983;9:375-82.
50. Paul R, Paul R, Jansen CT. Itch and malignancy prognosis in generalized pruritus: a 6-year follow-up of 125 patients. J Am Acad Dermatol 1987;16:1179-82.
51. Sweet RD. An acute febrile neutrophilic dermatosis. Br J Dermatol 1964;76:349-56.
52. Cohen PR, Talpaz M, Kurzrock R. Malignancy-associated Sweet's syndrome: review of the world literature. J Clin Oncol 1988;6:1887-97.
53. Cohen PR, Holder WR, Tucker SB, Kono S, Kurzrock R. Sweet syndrome in patients with solid tumors. Cancer 1993; 72:2723-31.
54. Cohen PR, Kurzrock R. Treatment of Sweet's syndrome [Letter]. Am J Med 1990;89:396.
55. Guin JD, Elleman JH. Yellow nail syndrome. Possible association with malignancy. Arch Dermatol 1979;115:734-5.
56. Haines D. Primary carcinoma duplex associated with tylosis. J R Nav Med Serv 1967;53:75-8.
57. Möhrenschlager M, Köhler LD, Bruckbauer H, Walch A, Ring J. Squamous epithelial carcinoma-associated necrolytic migratory erythema [in German]. Hautarzt 1999;50:198-202.
58. Soga J. Carcinoids and their variant endocrinomas. An analysis of 11842 reported cases. J Exp Clin Cancer Res 2003; 22:517-30.
59. Soga J. Early-stage carcinoids of the gastrointestinal tract: an analysis of 1914 reported cases. Cancer 2005;103:1587-95.
60. Soga J, Yakuwa Y, Osaka M. Carcinoid syndrome: a statistical evaluation of 748 reported cases. J Exp Clin Cancer Res 1999;18:133-41.
61. Ferlito A, Rinaldo A. The spectrum of endocrinocarcinomas of the larynx. Oral Oncol 2005;41:878-83.
62. Ferlito A, Devaney KO, Rinaldo A. Neuroendocrine neoplasms of the larynx: advances in identification, understanding, and management. Oral Oncol 2006;42:770-88.
63. Baugh RF, Wolf GT, Lloyd RV, McClatchey KD, Evans DA. Carcinoid (neuroendocrine carcinoma) of the larynx. Ann Otol Rhinol Laryngol 1987;96:315-21.
64. Kumai M, Arakawa T, Nakane T, et al. Serum serotonin elevated carcinoid tumor of the larynx [in Japanese]. Larynx Jpn 1996;8:53-5.
65. Overholt SM, Donovan DT, Schwartz MR, Laucirica R, Green LK, Alford BR. Neuroendocrine neoplasms of the larynx. Laryngoscope 1995;105:789-94.
66. Wenig BM, Gnepp DR. The spectrum of neuroendocrine carcinomas of the larynx. Semin Diagn Pathol 1989;6:329-50.
67. Yamanaka J, Yao K, Kohno H. A case of primary laryngeal carcinoid with the carcinoid syndrome and rapid clinical course [in Japanese]. Kitasato Med 1997;27:110-3.
68. Trotoux J, Glickmanas M, Sterkers O, Trousset M, Pinel J. Syndrome de Schwartz-Bartter. Révélateur d'un cancer laryngé sous-glottique à petites cellules. Ann Otolaryngol Chir Cervicofac 1979;96:349-58.
69. Medina JE, Moran M, Goepfert H. Oat cell carcinoma of the larynx and Eaton-Lambert syndrome. Arch Otolaryngol 1984;110:123-6.
70. Bishop JW, Osamura RY, Tsutsumi Y. Multiple hormone production in an oat cell carcinoma of the larynx. Acta Pathol Jpn 1985;35:915-23.
71. Takeuchi K, Nishii S, Jin CS, Ukai K, Sakakura Y. Anaplastic small cell carcinoma of the larynx. Auris Nasus Larynx 1989;16:127-32.
72. Myers TJ, Kessimian N. Small cell carcinoma of the larynx and ectopic antidiuretic hormone secretion. Otolaryngol Head Neck Surg 1995;113:301-4.
73. Imura H, Matsukura S, Yamamoto H, Hirata Y, Nakai Y. Studies on ectopic ACTH-producing tumors. II. Clinical and biochemical features of 30 cases. Cancer 1975;35:1430-7.
74. Schwartz WB, Bennett W, Curelop S, Bartter FC. A syndrome of renal sodium loss and hyponatremia probably resulting from inappropriate secretion of antidiuretic hormone. Am J Med 1957;23:529-42.
75. van Oosterhout AGM, van de Pol M, ten Velde GPM, Twijnstra A. Neurologic disorders in 203 consecutive patients with small cell lung cancer. Results of a longitudinal study. Cancer 1996;77:1434-41.
76. Sthoeger ZM, Breisilovsky S, Sthoeger D, Shani A, Geltner D. Syndrome of inappropriate antidiuretic hormone secretion following cis- dichlorodiammineplatinum II in a patient with laryngeal carcinoma. Eur J Med 1993;2:175-6.
77. Kandylis KV, Vasilomanolakis M, Efremides AD. Syndrome of inappropriate antidiuretic hormone secretion in pyriform sinus squamous cell carcinoma [Letter]. Am J Med 1986; 81:946.
78. Moses AM, Miller M, Streeten DHP. Pathophysiologic and pharmacologic alterations in the release and action of ADH. Metabolism 1976;25:697-721.
79. Roth Y, Lightman SL, Kronenberg J. Hyponatremia associated with laryngeal squamous cell carcinoma. Eur Arch Otorhinolaryngol 1994;251:183-5.
80. Talmi YP, Hoffman HT, McCabe BF. Syndrome of inappropriate secretion of arginine vasopressin in patients with cancer of the head and neck. Ann Otol Rhinol Laryngol 1992;101: 946-9.
81. Zohar Y, Talmi YP, Finkelstein Y, Nobel M, Gafter U. Syndrome of inappropriate antidiuretic hormone secretion in cancer of the head and neck. Ann Otol Rhinol Laryngol 1991; 100:341-4.
82. Vasan NR, Medina JE, Canfield VA, Gillies EM. Sinonasal neuroendocrine carcinoma in association with S1ADH. Head Neck 2004;26:89-93.
83. Suzuki M, Yoshida K, Watanabe T. Inappropriate secretion of antidiuretic hormone caused by the local regional recurrence of hypopharyngeal cancer. Otolaryngol Head Neck Surg 1998;118:412-4.
84. Maxwell EL, Witterick IJ. Syndrome of inappropriate antidiuretic hormone in a patient with metastatic supraglottic cancer. J Otolaryngol 2004;33:308-9.
85. Mundy GR. Ectopic production of calciotropic peptides. Endocrinol Metab Clin North Am 1991;20:473-87.
86. Mundy GR, Ibbotson KJ, D'Souza SM, Simpson EL, Jacobs JW, Martin TJ. The hypercalcemia of cancer. Clinical implications and pathogenic mechanisms. N Engl J Med 1984; 310:1718-27.
87. Gellhorn A, Plimpton CH. Hypercalcemia in malignant disease without evidence of bone destruction. Am J Med 1956; 21:750-9.
88. Angel MF, Stewart A, Pensak ML, Pillsbury HRC, Sasaki CT. Mechanisms of hypercalcemia in patients with head and neck cancer. Head Neck Surg 1982;5:125-9.
89. Minotti AM, Kountakis SE, Stiernberg CM. Paraneoplastic syndromes in patients with head and neck cancer. Am J Otolaryngol 1994;15:336-43.
90. Trousseau A. Phlegmasia alba dolens. Clinique Medicale de l'Hôtel-Dieu de Paris. London: New Sydenham Society, 1865;3:94.
91. Evans TRJ, Mansi JL, Bevan DH. Trousseau's syndrome in association with ovarian carcinoma. Cancer 1996;77:2544-9.
92. Sack GH Jr, Levin J, Bell WR. Trousseau's syndrome and other manifestations of chronic disseminated coagulopathy in patients with neoplasms: clinical, pathophysiologic, and therapeutic features. Medicine (Baltimore) 1977;56:1-37.
93. Nikšic M, Balogh M. Über Gerinnungsstörungen bei Kehlkopf- und Rachen-malignomen. Laryngol Rhinol Otol (Stuttg) 1976;55:414-9.
94. Naschitz JE, Yeshurun D, Eldar S, Lev LM. Diagnosis of cancer-associated vascular disorders. Cancer 1996;77:1759-67.
95. Liu PG, Jacobs JB, Reede D. Trousseau's syndrome in the head and neck. Am J Otolaryngol 1985;6:405-8.
96. Garcin R, Lapresle J. Sur un cas d'atrophie cérébelleuse corticale subaigue en relation avec un épithélioma du larynx. Arch Pathol 1956;62:399-402.
97. Müller E, Spanke O, Lehmann I. Neurogene Störungen bei extrazerebralen Malignomen. Med Klin 1969;64:1470-5.
98. Baloh RW. Paraneoplastic cerebellar disorders. Otolaryngol Head Neck Surg 1995;112:125-7.
99. Cher LM, Hochberg FH, Teruya J, et al. Therapy for paraneoplastic neurologic syndromes in six patients with protein A column immunoadsorption. Cancer 1995;75:1678-83.
100. Garcia FJ, Blazquez JA, Perez-Moro E, Martinez S. Paraneoplastic ataxia due to laryngeal carcinoma [in Spanish]. Acta Otorrinolaringol Esp 1998;49:414-5.
101. Lambert E, Eaton L, Rooke E. Defect of neuromuscular conduction associated with malignant neoplasm. Am J Physiol 1956;187:612.
102. Eaton LM, Lambert EH. Electromyography and electric stimulation of nerves in diseases of motor unit; observations on myasthenic syndrome associated with malignant tumors. J Am Med Assoc 1957;163:1117-24.
103. Gray TC, Halton J. Idiosyncracy to d-tubocurarine chloride. Br Med J 1948;1:784-6.
104. Seute T, Leffers P, ten Velde GP, Twijnstra A. Neurologic disorders in 432 consecutive patients with small cell lung carcinoma. Cancer 2004;100:801-6.
105. Fontanel J-P, Betheuil MJ, Sénéchal G, Haguenau M. Un cas de syndrome de Lambert-Eaton secondaire à un épithélioma laryngé. Ann Otolaryngol Chir Cervicofac 1973;90:314-7.
106. Ferroir JP, Hervier-Caen C, Reignier A, Nicolle MH, Guillard A. Remission of Lambert-Eaton syndrome over a 10-year period. Recurrence without evidence of tumor at autopsy [in French]. Rev Neurol (Paris) 1989;145:851-2.
107. Wymenga AN, Slebos DJ, van der Naalt J, van Putten JW, Peters FT. Abdominal complaints and neurological symptoms as an early sign of lung cancer: a manifestation of the anti-Hu syndrome [in Dutch]. Ned Tijdschr Geneeskd 2003;147:616-9.
108. Baijens LW, Manni JJ. Paraneoplastic syndromes in patients with primary malignancies of the head and neck. Four cases and a review of the literature. Eur Arch Otorhinolaryngol 2006;263:32-6.
109. Sobas MA, Galiano Leis MA, de la Fuente Cid R, Pereiro Zabala I. Paraneoplastic limbic encephalitis and epidermoid carcinoma of the pyriform [in Spanish]. An Med Interna 2006;23: 331-4.
110. Stummvoll GH, Aringer M, Machold KP, Smolen JS, Raderer M. Cancer polyarthritis resembling rheumatoid arthritis as a first sign of hidden neoplasms. Report of two cases and review of the literature. Scand J Rheumatol 2001;30:40-4.
111. Eggelmeijer F, Macfarlane JD. Polyarthritis as the presenting symptom of the occurrence and recurrence of a laryngeal carcinoma. Ann Rheum Dis 1992;51:556-7.
112. Sandoval M, Girons Bonells J, Foglia Fernandez M, Amilibia Cabeza E. Paraneoplastic syndrome as a manifestation of cancer of the hypopharynx [in Spanish]. Acta Otorrinolaringol Esp 1999;50:405-9.
113. Cabane J, Lebas J, Wattiaux MJ, Imbert JC. Pseudo-Still disease and neoplasm. 2 cases [in French]. Rev Med Interne 1988;9:81-4.
114. Scheuermann K, Delank KW. Paraneoplastic syndromes in ENT surgery [in German]. HNO 2003;51:332-6.
115. Bataller L, Dalmau J. Neuro-ophthalmology and paraneoplastic syndromes. Curr Opin Neurol 2004;17:3-8.
116. Chan JW. Paraneoplastic retinopathies and optic neuropathies. Surv Ophthalmol 2003;48:12-38.
117. Salgia R, Hedges TR, Rizk M, Reimer RH, Skarin AT. Cancer-associated retinopathy in a patient with non-small-cell lung carcinoma. Lung Cancer 1998;22:149-52.
118. Harmon JP, Purvin VA, Guy J, Aptsiauri N, Sutton GP. Cancer-associated retinopathy in a patient with advanced epithelial ovarian carcinoma. Gynecol Oncol 1999;73:430-2.
119. Adamus G, Ren G, Weleber RG. Autoantibodies against retinal proteins in paraneoplastic and autoimmune retinopathy. BMC Ophthalmol 2004;4:5.
120. To KW, Thirkill CE, Jakobiec FA, Lessell S, Berson EL. Lymphoma-associated retinopathy. Ophthalmology 2002;109: 2149-53.
121. Matsui Y, Mehta MC, Katsumi O, Brodie SE, Hirose T. Electrophysiological findings in paraneoplastic retinopathy. Graefes Arch Clin Exp Ophthalmol 1992;230:324-8.
122. Yamada G, Ohguro H, Aketa K, et al. Invasive thymoma with paraneoplastic retinopathy. Hum Pathol 2003;34:717-9.
123. Parc CE, Azan E, Bonnel S, Sahel JA, Kaplan J, Thirkill CE. Cone dysfunction as a paraneoplastic syndrome associated with retinal antigens approximating 40 kiloDalton. Ophthalmic Genet 2006;27:57-61.